185 related articles for article (PubMed ID: 7867796)
1. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct.
Toyokuni S; Miyake N; Hiai H; Hagiwara M; Kawakishi S; Osawa T; Uchida K
FEBS Lett; 1995 Feb; 359(2-3):189-91. PubMed ID: 7867796
[TBL] [Abstract][Full Text] [Related]
2. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies.
Uchida K; Itakura K; Kawakishi S; Hiai H; Toyokuni S; Stadtman ER
Arch Biochem Biophys; 1995 Dec; 324(2):241-8. PubMed ID: 8554315
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of actin to modification by 4-hydroxy-2-nonenal.
Ozeki M; Miyagawa-Hayashino A; Akatsuka S; Shirase T; Lee WH; Uchida K; Toyokuni S
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):119-26. PubMed ID: 15886073
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of protein-bound endogenous aldehydes. Chemical and immunochemical characterizations of configurational isomers of a 4-hydroxy-2-nonenal-histidine adduct.
Hashimoto M; Sibata T; Wasada H; Toyokuni S; Uchida K
J Biol Chem; 2003 Feb; 278(7):5044-51. PubMed ID: 12473681
[TBL] [Abstract][Full Text] [Related]
5. Bispecific abs against modified protein and DNA with oxidized lipids.
Akagawa M; Ito S; Toyoda K; Ishii Y; Tatsuda E; Shibata T; Yamaguchi S; Kawai Y; Ishino K; Kishi Y; Adachi T; Tsubata T; Takasaki Y; Hattori N; Matsuda T; Uchida K
Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6160-5. PubMed ID: 16603628
[TBL] [Abstract][Full Text] [Related]
6. Epitope mapping and characterization of 4-hydroxy-2-nonenal modified-human serum albumin using two different polyclonal antibodies.
Campos-Pinto I; Méndez L; Schouten J; Wilkins J; Fedorova M; Pitt AR; Davis P; Spickett CM
Free Radic Biol Med; 2019 Nov; 144():234-244. PubMed ID: 31075498
[TBL] [Abstract][Full Text] [Related]
7. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER
Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins.
Waeg G; Dimsity G; Esterbauer H
Free Radic Res; 1996 Aug; 25(2):149-59. PubMed ID: 8885333
[TBL] [Abstract][Full Text] [Related]
9. Maillard reaction-like lysine modification by a lipid peroxidation product: immunochemical detection of protein-bound 2-hydroxyheptanal in vivo.
Itakura K; Furuhata A; Shibata N; Kobayashi M; Uchida K
Biochem Biophys Res Commun; 2003 Aug; 308(3):452-7. PubMed ID: 12914770
[TBL] [Abstract][Full Text] [Related]
10. Serum 4-hydroxy-2-nonenal-modified albumin is elevated in patients with type 2 diabetes mellitus.
Toyokuni S; Yamada S; Kashima M; Ihara Y; Yamada Y; Tanaka T; Hiai H; Seino Y; Uchida K
Antioxid Redox Signal; 2000; 2(4):681-5. PubMed ID: 11213473
[TBL] [Abstract][Full Text] [Related]
11. Lipid peroxidation generates body odor component trans-2-nonenal covalently bound to protein in vivo.
Ishino K; Wakita C; Shibata T; Toyokuni S; Machida S; Matsuda S; Matsuda T; Uchida K
J Biol Chem; 2010 May; 285(20):15302-15313. PubMed ID: 20215107
[TBL] [Abstract][Full Text] [Related]
12. Measurement of HNE-protein adducts in human plasma and serum by ELISA-Comparison of two primary antibodies.
Weber D; Milkovic L; Bennett SJ; Griffiths HR; Zarkovic N; Grune T
Redox Biol; 2013; 1(1):226-33. PubMed ID: 24024156
[TBL] [Abstract][Full Text] [Related]
13. Crystallization and molecular-replacement studies of the monoclonal antibody mAbR310 specific for the (R)-HNE-modified protein.
Ito S; Tatsuda E; Ishino K; Suzuki K; Sakai H; Uchida K
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Jun; 62(Pt 6):562-4. PubMed ID: 16754982
[TBL] [Abstract][Full Text] [Related]
14. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts.
Hartley DP; Kroll DJ; Petersen DR
Chem Res Toxicol; 1997 Aug; 10(8):895-905. PubMed ID: 9282839
[TBL] [Abstract][Full Text] [Related]
15. Protein-bound 4-hydroxy-2-nonenal: an endogenous triggering antigen of antI-DNA response.
Toyoda K; Nagae R; Akagawa M; Ishino K; Shibata T; Ito S; Shibata N; Yamamoto T; Kobayashi M; Takasaki Y; Matsuda T; Uchida K
J Biol Chem; 2007 Aug; 282(35):25769-78. PubMed ID: 17588942
[TBL] [Abstract][Full Text] [Related]
16. Combined proteomic approaches for the identification of specific amino acid residues modified by 4-hydroxy-2-nonenal under physiological conditions.
Mendez D; Hernaez ML; Diez A; Puyet A; Bautista JM
J Proteome Res; 2010 Nov; 9(11):5770-81. PubMed ID: 20818828
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry-based proteomics of oxidative stress: Identification of 4-hydroxy-2-nonenal (HNE) adducts of amino acids using lysozyme and bovine serum albumin as model proteins.
Aslebagh R; Pfeffer BA; Fliesler SJ; Darie CC
Electrophoresis; 2016 Oct; 37(20):2615-2623. PubMed ID: 27184861
[TBL] [Abstract][Full Text] [Related]
18. Identification of 4-hydroxy-2-nonenal-histidine adducts that serve as ligands for human lectin-like oxidized LDL receptor-1.
Kumano-Kuramochi M; Shimozu Y; Wakita C; Ohnishi-Kameyama M; Shibata T; Matsunaga S; Takano-Ishikawa Y; Watanabe J; Goto M; Xie Q; Komba S; Uchida K; Machida S
Biochem J; 2012 Feb; 442(1):171-80. PubMed ID: 22077443
[TBL] [Abstract][Full Text] [Related]
19. Detection of lipofuscin-like fluorophore in oxidized human low-density lipoprotein. 4-hydroxy-2-nonenal as a potential source of fluorescent chromophore.
Itakura K; Oya-Ito T; Osawa T; Yamada S; Toyokuni S; Shibata N; Kobayashi M; Uchida K
FEBS Lett; 2000 May; 473(2):249-53. PubMed ID: 10812084
[TBL] [Abstract][Full Text] [Related]
20. Chemical characterization of a protein-4-hydroxy-2-nonenal cross-link: immunochemical detection in mitochondria exposed to oxidative stress.
Cohn JA; Tsai L; Friguet B; Szweda LI
Arch Biochem Biophys; 1996 Apr; 328(1):158-64. PubMed ID: 8638925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
